Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Fatigue 14Neoplasms 6Brain Neoplasms 5Prostatic Neoplasms 4Depression 4Sleep Wake Disorders 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Central Nervous System Neoplasms 2Breast Neoplasms 2Asthenia 2Recurrence 1Oligodendroglioma 1Neurotoxicity Syndromes 1Neurofibromatosis 1 1Neuroectodermal Tumors, Primitive 1Neoplasm Metastasis 1Meningioma 1Hematologic Neoplasms 1Gliosarcoma 1Glioma, Subependymal 1Glioma 1Glioblastoma 1Gastrointestinal Neoplasms 1Ependymoma 1Cognitive Dysfunction 1Astrocytoma 1Anxiety Disorders 1

Interventions

Music Therapy 15Cognitive Behavioral Therapy 13Therapeutics 12Surveys and Questionnaires 12Psychiatric Rehabilitation 9Methods 9Standard of Care 8Psilocybin 7Educational Status 7Mindfulness 6Hypnosis 6Early Intervention, Educational 6Mindfulness-Based Stress Reduction 5Mindfulness-Based Cognitive Therapy 5Massage 5Control Groups 5Art Therapy 5Aromatherapy 5Saline Solution 4Ketamine 4Interviews as Topic 4Imagery, Psychotherapy 4Esketamine 4Behavior Therapy 4Autogenic Training 4Acupuncture Therapy 4Yoga 3Weights and Measures 3Touch 3Therapeutic Touch 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Anxiety Disorders × Methylphenidate × Clear all
NCT05474846 2025-11-06

Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer

M.D. Anderson Cancer Center

Phase 2/3 Recruiting
188 enrolled

Anxiety Disorders, Depression, Fatigue, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡